According to an analysis by Triton Market Research, the protein expression market in North America is likely to augment at a CAGR of 11.35% over the forthcoming period between 2019 and 2028.
The countries evaluated in the North American protein expression market are:
• Canada
• The United States
In the United States, biopharmaceutical sales account for about 30% of the total pharmaceutical sales in the country. The majority of the biopharmaceutical products that have reached the US market are developed in just a few expression systems. There is a tremendous increase in the number of pharmaceutical industries in the country. It is also home to many big research & academic institutions and biotechnology industries across the world.
Many mammalian proteins, like insulin, growth hormones, antibodies and vaccines, are produced industrially in the US. The increasing investments towards the research & development of such products, will push the demand for protein expression systems. Currently, many government initiatives have been launched to aid the growth of the cell-free protein expression market in the US. For example, the Precision Medicine Initiative was launched to revolutionize the treatment of various chronic disorders. These favorable government initiatives are aiding the pharmaceutical and biotechnology firms to develop protein-based therapeutics, thereby helping the studied market growth.
Canada is also considered as one of the major hubs for biopharmaceutical companies and is actively involved in R&D of new therapeutics for protein expressions. It is reported that the protein ‘human dopamine D2 receptor long isoform (D2L)’ has significant implications in neurological and neuropsychiatric disorders, like schizophrenia and Parkinson’s disease. These developments are aiding the potential application of protein expression in the regional market.
Agilent Technologies Inc is a company providing solutions to the field of diagnostics, life sciences and applied chemical markets across the world. It has three major business operational segments, diagnostics & genomics, life sciences & applied markets and Agilent CrossLab. The diagnostics & genomics segment mainly provides a wide range of protein expression products, including competent cells for difficult protein expression. The company has its headquarters in California, the US.
Some prominent companies in the protein expression market are Biotechrabbit, Promega Corporation, Takara Holdings Inc, Dickinson and Company), Lonza, Merck KGaA, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Peak Proteins Ltd, Qiagen, ProMab, Agilent Technologies Inc, BD (Becton, GenScript, New England Biolabs and LifeSensors.